Division of Clinical Neurosciences, Turku University Hospital, Turku, Finland.
Department of Neurology, University of Turku, Turku, Finland.
Acta Neurol Scand. 2019 Apr;139(4):353-359. doi: 10.1111/ane.13057. Epub 2019 Jan 3.
Studies on the east-west gradient of multiple sclerosis (MS) are scarce. In Finland, epidemiological differences have been only partially elucidated, but the MS risk is high, and it has been claimed that the occurrence follows a longitudinal gradient. In this register-based study, we updated the MS epidemiology in southwest Finland (SwF) and compared it to the easternmost hospital district, North Karelia (NK), for which no previous data exist.
Patients with ICD-10 code G35 were identified from hospital district administrative data. Patient records were reviewed to include only cases with a definitive diagnosis. Incidence period covered 5 years (2012-2016), and the prevalence date was December 31, 2016. Results were standardized using the direct method.
A total of 1184 persons had MS in SwF and 253 persons in NK at the end of 2016. The prevalence was 280/100 000 (95% CI 264-296) in SwF and 168/100 000 (95% CI 148-190) in NK (age-standardized for the European standard population 2013). During the incidence period, 211 new MS diagnoses were made in SwF and 49 in NK. The annual age-standardized (ESP 2013) incidence was 12.1/100 000 person-years (95% CI 10.5-13.8) in SwF and 8.6/100 000 person-years (95% CI 6.4-11.2) in NK in the age-group 10-69 years.
There are regional differences in MS epidemiology in Finland, possibly related to demographic, social, and genetic circumstances, but the retrospective nature and limited sample size of this study might introduce some uncertainty to the calculations. SwF is a region with a globally very high risk for MS.
多发性硬化症(MS)的东西梯度研究较少。在芬兰,流行病学差异仅部分阐明,但 MS 风险很高,有人声称其发生遵循纵向梯度。在这项基于登记的研究中,我们更新了芬兰西南部(SwF)的 MS 流行病学,并将其与以前没有数据的最东端医院区北卡累利阿(NK)进行了比较。
从医院区行政数据中确定 ICD-10 代码 G35 的患者。对患者记录进行审查,仅包括具有明确诊断的病例。发病期为 5 年(2012-2016 年),患病率日期为 2016 年 12 月 31 日。结果采用直接法标准化。
到 2016 年底,SwF 共有 1184 人患有 MS,NK 有 253 人患有 MS。SwF 的患病率为 280/100 000(95%CI 264-296),NK 的患病率为 168/100 000(95%CI 148-190)(年龄标准化为 2013 年欧洲标准人口)。发病期间,SwF 确诊 211 例新 MS 病例,NK 确诊 49 例。10-69 岁年龄组中,SwF 的年标准化(ESP 2013)发病率为 12.1/100 000 人年(95%CI 10.5-13.8),NK 为 8.6/100 000 人年(95%CI 6.4-11.2)。
芬兰的 MS 流行病学存在地域差异,可能与人口统计学、社会和遗传环境有关,但本研究的回顾性和有限的样本量可能会给计算带来一些不确定性。SwF 是全球 MS 风险非常高的地区。